BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report) insider Jon Rousseau sold 235,000 shares of the stock in a transaction dated Wednesday, October 22nd. The stock was sold at an average price of $28.78, for a total transaction of $6,763,300.00. Following the completion of the sale, the insider directly owned 1,131,930 shares in the company, valued at $32,576,945.40. This trade represents a 17.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
BrightSpring Health Services Stock Performance
BrightSpring Health Services stock opened at $32.94 on Thursday. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.76 and a quick ratio of 1.34. BrightSpring Health Services, Inc. has a 1-year low of $14.73 and a 1-year high of $33.16. The firm has a market capitalization of $5.96 billion, a P/E ratio of 54.00, a price-to-earnings-growth ratio of 0.49 and a beta of 2.40. The company’s 50-day moving average is $26.87 and its 200 day moving average is $22.95.
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last posted its quarterly earnings data on Monday, October 20th. The company reported $0.30 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.03. The company had revenue of $3.33 billion for the quarter, compared to analyst estimates of $3.16 billion. BrightSpring Health Services had a net margin of 1.04% and a return on equity of 11.83%. BrightSpring Health Services has set its Q3 2025 guidance at 0.300-0.300 EPS. FY 2025 guidance at EPS. Research analysts forecast that BrightSpring Health Services, Inc. will post 0.59 EPS for the current year.
Hedge Funds Weigh In On BrightSpring Health Services
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on the stock. Wall Street Zen lowered shares of BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 26th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of BrightSpring Health Services in a research report on Wednesday, October 8th. Jefferies Financial Group set a $36.00 target price on shares of BrightSpring Health Services and gave the stock a “buy” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft set a $30.00 target price on shares of BrightSpring Health Services and gave the stock a “buy” rating in a research report on Monday, September 8th. Finally, Wells Fargo & Company raised their target price on shares of BrightSpring Health Services from $27.00 to $33.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Ten investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $32.56.
Check Out Our Latest Research Report on BTSG
BrightSpring Health Services Company Profile
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Featured Articles
- Five stocks we like better than BrightSpring Health Services
- How to trade using analyst ratings
- Archer’s Recent String of Victories Signals a New Phase of Growth
- How to Invest in the FAANG Stocks
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- Upcoming IPO Stock Lockup Period, Explained
- The Best AI for Picking Stocks, Ranked by Performance
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.